Europe egg scare: Belgium discovered contamination in June
Belgian food safety authorities began investigating possible pesticide contamination in eggs in early June, several weeks before the public was made aware of a food safety scare now affecting several European countries.
Convicted 'Pharma Bro' has an image problem, lawyer concedes
Jurors are deliberating for a fifth day at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).
GM recalling roughly 800,000 pickups for steering defect
General Motors Co. is recalling roughly 800,000 Chevrolet Silverado 1500 and GMC Sierra 1500 pickup trucks worldwide.
'Pharma Bro' Shkreli trial verdict: Guilty on 3 counts of 8
Martin Shkreli, who caught fire for hiking drug prices, was convicted Friday on three federal charges that he deceived investors.
Maine Governor proposes Medicaid recipients to work for benefits
Gov. Paul LePage on health care
Recalls this week: iPhone cases, children's building sets
More than 250,000 glitter iPhone cases are being recalled because glitter can leak, causing skin irritation and burns.
Employer-based health coverage likely to stay awhile
The battle over Obamacare is unlikely to hurt company health plans...for now.
Toyota, Mazda to build $1.6 billion plant in US
The Japanese automakers announced on Friday a plan to build a $1.6 billion factory in the U.S., creating up to 4,000 new jobs.
Eli Lilly's new migraine drug succeeds in late-stage study
Eli Lilly and Company announced Friday that its new drug for acute migraines, lasmiditan, has met its primary endpoint in a second Phase 3 study and the company plans to submit for FDA approval during the second half of 2018.
German supermarket chain yanks eggs amid pesticide scare
A major supermarket chain is removing all eggs from sale in its German stores amid a scare over possible pesticide contamination.
Cigna beats profit estimates, raises FY profit view
Cigna reported a better-than-expected quarterly profit on Friday on strength in its commercial business and the health insurer also raised its full year profit forecast.
Asian stocks mixed as US jobs, politics in focus
U.S. stocks are edging lower in early trading Thursday as banks, technology and health companies fall.
FDA OKs new drug to treat all forms of hepatitis C
U.S. regulators have approved the first drug to treat all forms of hepatitis C in as little as eight weeks.
Ford works with police agencies after cops sickened by fumes
A growing number of police departments across the country are taking action over concerns that carbon monoxide fumes from Ford Explorer patrol vehicles are seeping inside the SUVs, potentially sickening officers.
No verdict after 4th day of deliberations in Shkreli trial
Jurors are on their fourth day of deliberations at the securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).
FDA OKs new drug to treat all forms of hepatitis C
U.S. regulators have approved another drug to treat all forms of hepatitis C that works in as little as eight weeks.
Senate passes legislation to ensure no halt in FDA reviews
The Senate has passed legislation increasing the user fees that drug and medical device-makers pay.
US Governors urge Trump to continue ObamaCare subsidy payments
Democratic and Republican U.S. governors on Wednesday urged the Trump administration, as well as Congress, to continue funding payments to health insurance companies that make Obamacare plans affordable, calling it critical to stabilizing the insurance marketplace.
Gene editing raises legal, ethical problems with designer babies: Judge Napolitano
Fox News senior judicial analyst Judge Andrew Napolitano discusses the legal and ethical fallout from the breakthrough in gene editing.
Aetna hikes outlook after ObamaCare pullback
Aetna's second-quarter profit jumped 52 percent, topping Wall Street expectations, and it raised its 2017 forecast again, this time well beyond analyst projections.













